Horizon Kinetics · 1999-09-30 成立 · 规模、费率、NAV、资金流、完整持仓和风险收益使用各自可追溯公开源。
| 日期 | 估算净流 | 申购 / 销售 | 赎回 | 净资产 | 口径 |
|---|---|---|---|---|---|
| 2026-07-31 | +$405,485 | — | — | $19.1M | 每日估算 |
| 2026-07-30 | +$1.8M | — | — | $19.1M | 每日估算 |
| 2026-07-29 | -$176,464 | — | — | $17.4M | 每日估算 |
| 2026-07-28 | -$1.7M | — | — | $17.4M | 每日估算 |
| 2026-07-27 | -$65,261 | — | — | $19.1M |
| 持仓 | 资产类别 | 数量 | 市值 | 权重 |
|---|---|---|---|---|
LLY Eli Lilly & Co | EC | 3,077 | $2.8M | 15.59% |
USBGFS7 US BANK MMDA - USBGFS 7 | STIV | 1,820,804 | $1.8M | 10.03% |
ABBV AbbVie Inc | EC | 7,034 | $1.5M | 8.43% |
NVS Novartis AG | EC | 8,791 |
行情与风险截至 2026-07-30；NAV 的发布时间可能和交易所收盘错位。完整持仓是延迟监管披露，不代表当前盘中组合。
已使用：nasdaq_etf_screener、yahoo_chart、yahoo_quote_summary、sec_nport。缺口标记：nav_timestamp_unverified、category_reclassified_by_current_taxonomy。
| 每日估算 |
| 2026-07-26 | -$65,261 | — | — | $19.1M | 每日估算 |
| 2026-07-25 | +$1.7M | — | — | $19.1M | 每日估算 |
| 2026-03-31 | -$808,785 | $0 | $808,785 | $18.2M | SEC 月度 |
| 2026-02-28 | $0 | $0 | $0 | — | SEC 月度 |
| 2026-01-31 | $0 | $0 | $0 | — | SEC 月度 |
| $1.3M |
| 7.40% |
JNJ Johnson & Johnson | EC | 4,401 | $1.1M | 5.93% |
AZN AstraZeneca PLC | EC | 5,256 | $1.0M | 5.71% |
BMY Bristol-Myers Squibb Co | EC | 15,348 | $930,856 | 5.13% |
IONS Ionis Pharmaceuticals Inc | EC | 11,428 | $858,129 | 4.73% |
AMGN Amgen Inc | EC | 2,161 | $760,348 | 4.19% |
ALNY Alnylam Pharmaceuticals Inc | EC | 2,272 | $751,737 | 4.14% |
ALKS Alkermes PLC | EC | 21,099 | $746,061 | 4.11% |
MRK Merck & Co Inc | EC | 6,154 | $740,265 | 4.08% |
PFE Pfizer Inc | EC | 23,736 | $666,507 | 3.67% |
GSK GSK PLC | EC | 10,319 | $569,506 | 3.14% |
BIIB Biogen Inc | EC | 2,857 | $523,774 | 2.89% |
REGN Regeneron Pharmaceuticals Inc | EC | 660 | $509,942 | 2.81% |
CRSP CRISPR Therapeutics AG | EC | 9,671 | $460,049 | 2.53% |
BEAM Beam Therapeutics Inc | EC | 8,791 | $209,490 | 1.15% |
NTLA Intellia Therapeutics Inc | EC | 13,188 | $169,070 | 0.93% |
VNDA Vanda Pharmaceuticals Inc | EC | 23,736 | $164,016 | 0.90% |
SDZNY Sandoz Group AG | EC | 1,760 | $137,632 | 0.76% |
GALT Galectin Therapeutics Inc | EC | 49,226 | $137,341 | 0.76% |
HLN Haleon PLC | EC | 12,900 | $129,129 | 0.71% |
REPL Replimune Group Inc | EC | 13,188 | $100,888 | 0.56% |
EDIT Editas Medicine Inc | EC | 29,010 | $71,655 | 0.39% |
GEHC GE HealthCare Technologies Inc | EC | 880 | $62,638 | 0.35% |
BCYC Bicycle Therapeutics PLC | EC | 13,188 | $61,192 | 0.34% |
VTRS Viatris Inc | EC | 3,272 | $44,205 | 0.24% |
ALLO Allogene Therapeutics Inc | EC | 17,582 | $42,900 | 0.24% |
LTRN Lantern Pharma Inc | EC | 26,373 | $36,131 | 0.20% |
PACB Pacific Biosciences of California Inc | EC | 10,551 | $13,927 | 0.08% |
DCOY Decoy Therapeutics Inc | EC | 21 | $136 | 0.00% |
2368714D Pathos AI Inc | EC | 23,992 | $0 | 0.00% |